Researchers at the University of Arizona Cancer Center discovered a new class of iron-targeting compounds that hamper the proliferation of cultured malignant cells in a laboratory setting. The results of the study were published in the Journal of the American Chemical Society.
yet keeping it available to the rest of the body. To do so, they targeted intracellular iron with compounds that are activated only after cellular uptake."As chemists, we can design and synthesize molecules that are able to bind iron only under certain conditions and not throughout the body," Tomat said."We've been working on various approaches toward this type of chemistry; we call these prochelator approaches because the chelator is the compound that binds the metal ion.
The research was inspired by a"common reagent," a compound that is employed in laboratories worldwide to assess the ability of drug candidates to inhibit the proliferation of cultured mammalian cells. "Because iron is such a fundamental player that is important in many cancer types, and this high demand for iron is a general characteristic of malignancy, I've been interested in this strategy for a number of years," said Tomat, who has been exploring iron chelators and their role in tumor progression for more than 10 years.
"We're excited about this new strategy because we think this class of molecules can be further modified to optimize the properties and improve the antiproliferative activity and really become a way for us to impact theTomat's co-authors include former postdoctoral associate Zoufeng Xu, Ph.D., and doctoral student Yu-Shien Sung.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Cancer-causing mutations rewire growth signaling in prostate cancer modelExperts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators. This discovery has implications for potential therapeutics in prostate cancer and other cancer types as understanding more about this network remodeling and the drivers of cellular growth provides molecular targets for drugs to stop tumor progression.
Weiterlesen »
Study finds higher breast cancer risk after certain forms of childhood cancer treatmentThree out of four children with cancer are successfully treated and survive the disease. But the treatment, which often consists of a combination of surgery, chemotherapy and radiation, can cause serious side effects and late effects in some survivors. One of those late effects is developing a second cancer in adulthood.
Weiterlesen »
Taiwan's lung cancer early detection program detects 85% of lung cancer cases at early phaseThe Taiwan National Lung Cancer Early Detection Program detected 85% of lung cancer cases at either a phase 0 or phase 1 level, demonstrating that lung cancer screening can detect lung cancer at an early enough phase to allow doctors to intervene more effectively.
Weiterlesen »
Strathclyde named Scottish University of the Year and hailed as 'outstanding'The University of Strathclyde came out on top of the inaugural Daily Mail University Guide and Daily Mail University Awards with the judges describing it as 'outstanding'.
Weiterlesen »
High levels of particulate air pollution associated with increased breast cancer incidenceResearchers at the National Institutes of Health found that living in an area with high levels of particulate air pollution was associated with an increased incidence of breast cancer. The study, published in JNCI: Journal of the National Cancer Institute, is one of the largest studies to date looking at the relationship between outdoor air pollution, specifically fine particulate matter, and breast cancer incidence.
Weiterlesen »
Intensity-modulated radiation therapy provides long-term benefits to patients with locally advanced lung cancerIntensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the heart and lungs, according to researchers at The University of Texas MD Anderson Cancer Center.
Weiterlesen »